01/07/2015 - 9:17am

Lupin Pharmaceuticals on Tuesday launched its valsartan tablets USP in 40-, 80-, 160- and 320-mg dosage strengths. The drug is the generic version Novartis's Diovan tablets.

01/06/2015 - 2:19pm

Aurobindo Pharma on Tuesday announced that the company has received final approval from the U.S. Food & Drug Administration to manufacture and market Valsartan Tablets.

01/06/2015 - 2:09pm

Vermont Attorney General Bill Sorrell is investigating generic drug price inflation.

01/06/2015 - 12:31pm

According to the Walgreens Flu Index for the week beginning Jan. 5, Knoxville, Tenn. is the No. 1 designated market area with flu activity, followed by the Paducah, Ky. area and Chattanooga, Tenn.

01/05/2015 - 3:15pm

About half the country is experiencing high levels of flu activity.

 

01/05/2015 - 2:20pm

Mylan announced the introduction of valsartan tablets USP in 40-, 80-, 160- and 320-mg dosage strengths. 

01/05/2015 - 1:58pm

Keryx Biopharmaceuticals last month announced it has begun shipping Auryxia (ferric citrate) tablets to wholesalers in the United States. 

12/29/2014 - 11:26am

Genentech last week announced that the Food and Drug Administration approved a supplemental biologics license application for Gazyva to be used in combination with chlorambucil chemotherapy in people with previously untreated chronic lymphocytic leukemia.

12/29/2014 - 10:46am

In a staff memo, the Office of Generics Drug’s acting director, Kathleen Uhl, vowed to take action on 90% of the abbreviated new drug application backlog before October 2017, and has appointed Ted Sherwood as acting director of OGD’s Office of Regulatory Operations to help with the improvements, FDANews.com has reported.